Search Results

Cisplatin 25mg  | ≥99%

CSNpharm

Cisplatin is an inorganic platinum complex, which is able to inhibit DNA synthesis by conforming DNA adducts. It is used, alone or in combination therapy, in the treatment of several types of cancer, including testicular, ovarian, cervical, bladder, and lung cancers. Cisplatin also inhibits the RecA recombinase of M. tuberculosis (IC50 = 2 µM), blocking […]

More Information Supplier Page

Cisplatin 100mg  | ≥99%

CSNpharm

Cisplatin is an inorganic platinum complex, which is able to inhibit DNA synthesis by conforming DNA adducts. It is used, alone or in combination therapy, in the treatment of several types of cancer, including testicular, ovarian, cervical, bladder, and lung cancers. Cisplatin also inhibits the RecA recombinase of M. tuberculosis (IC50 = 2 µM), blocking […]

More Information Supplier Page

Clinofibrate 100mg  | ≥99%

CSNpharm

Clinofibrate is a HMG-CoA reductase inhibitor with IC50 value of 470 μM which can reduce plasma cholesterol levels and shows antihyperlipidemic effects.

More Information Supplier Page

Clinofibrate 10mg  | ≥99%

CSNpharm

Clinofibrate is a HMG-CoA reductase inhibitor with IC50 value of 470 μM which can reduce plasma cholesterol levels and shows antihyperlipidemic effects.

More Information Supplier Page

Clinofibrate 250mg  | ≥99%

CSNpharm

Clinofibrate is a HMG-CoA reductase inhibitor with IC50 value of 470 μM which can reduce plasma cholesterol levels and shows antihyperlipidemic effects.

More Information Supplier Page

Clinofibrate 5mg  | ≥99%

CSNpharm

Clinofibrate is a HMG-CoA reductase inhibitor with IC50 value of 470 μM which can reduce plasma cholesterol levels and shows antihyperlipidemic effects.

More Information Supplier Page

Clinofibrate 50mg  | ≥99%

CSNpharm

Clinofibrate is a HMG-CoA reductase inhibitor with IC50 value of 470 μM which can reduce plasma cholesterol levels and shows antihyperlipidemic effects.

More Information Supplier Page